Bachem Holding AG
BANB
Rangering i aksjer
#2516
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Aksjekurs
$100.60
Markedsverdi
$7.54B
Endring (1 dag)
-1.49%
Endring (1 år)
49.53%
Land
CH
Handel Bachem Holding AG (BANB)
Kategori
Healthcare
P/B-forhold for Bachem Holding AG (BANB)
P/B-forhold per October 2026 TTM: 4.31
Ifølge Bachem Holding AG sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 4.31. Ved slutten av 2024 hadde selskapet et P/B-forhold på 3.12.
P/B-historikk for Bachem Holding AG fra 2002 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 4.31 | 40.03% |
| 2025 | 3.08 | -1.34% |
| 2024 | 3.12 | -15.11% |
| 2023 | 3.68 | -26.96% |
| 2022 | 5.03 | -44.38% |
| 2021 | 9.05 | -22.23% |
| 2020 | 11.64 | 143.30% |
| 2019 | 4.78 | 18.05% |
| 2018 | 4.05 | -27.47% |
| 2017 | 5.59 | 66.84% |
| 2016 | 3.35 | 68.44% |
| 2015 | 1.99 | 4.79% |
| 2014 | 1.90 | -2.54% |
| 2013 | 1.95 | 29.71% |
| 2012 | 1.50 | 14.42% |
| 2011 | 1.31 | -37.56% |
| 2010 | 2.10 | -11.45% |
| 2009 | 2.37 | -17.55% |
| 2008 | 2.88 | -18.65% |
| 2007 | 3.54 | 13.43% |
| 2006 | 3.12 | -76.81% |
| 2005 | 13.44 | 424.43% |
| 2004 | 2.56 | 2,367.37% |
| 2003 | 0.10 | 11,444.44% |
| 2002 | 0.00 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 6.251 | 44.93% |
US
|
|
| 13.2547 | 207.32% |
US
|
|
| 4.4521 | 3.23% |
AU
|
|
| 6.3632 | 47.54% |
NL
|
|
| - | - |
CH
|
